Discussion 'Cancer'
Expanding Role of mRNA Platform with Nobel Laureate Dr. Drew Weissman
We are excited to welcome Nobel Laureate Dr. Drew Weissman from the University of Pennsylvania yet again on CureTalks. Dr.Weissman's groundbreaking research in messenger RNA (mRNA) technology earned him the Nobel Prize in Medicine, alongside his colleague Katalin Karikó. Their…
When should people get palliative care?
Palliative care is specialized medical care focused on relieving the symptoms and stress of a serious illness and improving quality of life, in alignment with a patient’s individual goals, values, and priorities. Although palliative care consultation is recommended for millions…
What’s New in Multiple Myeloma Management?
Multiple myeloma is diagnosed in over 100,000 patients each year worldwide. The FDA recently granted accelerated approval to Teclistamab, the first bispecific B-cell maturation (BCMA)-directed CD3 T-cell engager. The therapeutic armamentarium for myeloma now includes alkylating agents, corticosteroids, deacetylase inhibitors,…
Beyond CAR-T: Re-engineering Cells into Life-saving Therapies
Our cells have the innate ability to protect us. The idea of using cells as medicine emerged with bone marrow transplants, and then CAR-T therapy for blood cancers. Now, scientists are beginning to engineer much more complex living therapeutics by…
Diagnosis and Management of Waldenstrom’s Macroglobulinemia
Waldenstrom's macroglobulinemia (WM) is a rare type of cancer that begins in the white blood cells.The abnormal white blood cells produce a protein that accumulates in the blood, impairs circulation and causes complications. It continues to be a clinical challenge…